Donald I. Abrams, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Donald I. Abrams, MD

Professor, Department of Medicine, UCSF; Chief, Hematology-Oncology, San Francisco General Hospital; Director of Clinical Programs, Osher Center for Integrative Medicine

Phone: (415) 353-7720 (voice)
Box 0874, UCSF
San Francisco, CA 94143-0874

View on UCSF Profiles

Cancer Center Membership

Associate Member » Prostate Cancer» Cancer Control

Research Summary

Donald I. Abrams, M.D. is chief of the Hematology-Oncology Division at San Francisco General Hospital, an integrative oncologist at the UCSF Osher Center for Integrative Medicine and Professor of Clinical Medicine at the University of California San Francisco. He graduated from Brown University in 1972 and from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in Hematology-Oncology at the UCSF Cancer Research Institute in 1980. During his fellowship, Dr. Abrams spent eight months working in the retrovirology laboratory of Harold Varmus, M.D. during the time that the first cases of AIDS were being diagnosed. He subsequently returned to the clinical arena where he was one of the original clinician/investigators to recognize many of the early AIDS-related conditions. He conducted numerous clinical trials investigating conventional as well as complementary therapies in patients with HIV including therapeutic touch, Traditional Chinese Medicine interventions, medicinal mushrooms, medical marijuana and distant healing. His interest in botanical therapies led him to pursue a two-year Fellowship in the Program in Integrative Medicine at the University of Arizona which he completed in December 2004. His particular passion in the field involves nutrition and cancer. Since completing his Fellowship, Dr. Abrams has been providing Integrative Medicine consultation to people living with and beyond cancer at the UCSF Osher Center for Integrative Medicine. He co-edited an Oxford University Press textbook in Integrative Oncology with Andrew Weil, M.D.. He is a member of the NCI PDQ CAM Editorial Board. Dr. Abrams was President of the Society of Integrative Oncology in 2010.

Education

Brown University, Providence, RI, AB, 1972, Molecular Biology
Stanford Univ. School of Medicine, Stanford, CA, MD, 1977, Medicine
Kaiser Foundation Hospital, San Francisco, CA, 1980, Internal Medicine
Cancer Research Institute, UCSF, 1983, Hematology/Oncology
University of Arizona, Fellowship, Tucson, AZ, 2004, Integrative Medicine


Professional Experience

  • July 1982 - June 1983
    Assistant Research Physician, Cancer Research Institute, University of California, San Francisco
  • July 1983 - June 1984
    Clinical Instructor, Department of Medicine, San Francisco General Hospital and Cancer Research Institute, University of California, San Francisco
  • July 1983 - June 2003
    Assistant Director, AIDS Activities, San Francisco General Hospital
  • July 1984 - June 1988
    Assistant Clinical Professor, Department of Medicine, University of California, San Francisco
  • July 1985 - Sept 2006
    Chairman, Community Consortium of Bay Area HIV Health Care Providers
  • July 1988 - June 1992
    Associate Professor of Clinical Medicine, University of California, San Francisco
  • July 1992 - present
    Professor of Clinical Medicine, University of California San Francisco
  • July 2003 - present
    Chief, Hematology-Oncology, San Francisco General Hospital
  • August 2006 - present
    Director, Clinical Programs, Osher Center, University of California, San Francisco

Honors & Awards

  • 1986-89
    American Cancer Society Career Development Award
  • 1990
    Assistant Secretary of Health's Award for Outstanding Accomplishment
  • 2000
    American Foundation for AIDS Research Award of Courage
  • 2000
    International Association of Physicians in AIDS CARE (IAPAC) Heroes in Medicine Award
  • 2002
    UCSF AIDS Research Institute Sarlo Award for Excellence in Mentoring

Selected Publications

  1. Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS. 2015 Sep 24; 29(15):1943-51.
    View on PubMed
  2. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. J Pain. 2015 Dec; 16(12):1221-32.
    View on PubMed
  3. Integrative Medicine Patients Have High Stress, Pain, and Psychological Symptoms. Explore (NY). 2015 Jul-Aug; 11(4):296-303.
    View on PubMed
  4. Cannabis in cancer care. Clin Pharmacol Ther. 2015 Jun; 97(6):575-86.
    View on PubMed
  5. Survival among HIV-Infected and HIV-Uninfected Individuals with Common Non-AIDS-Defining Cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73.
    View on PubMed
  6. A Comparative Study of Molecular Characteristics of Diffuse Large B-cell Lymphoma from Patients with and without Human Immunodeficiency Virus Infection. Clin Cancer Res. 2015 Mar 15; 21(6):1429-37.
    View on PubMed
  7. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502.
    View on PubMed
  8. Milking the evidence: diet does matter. J Clin Oncol. 2014 Aug 1; 32(22):2290-2.
    View on PubMed
  9. Characteristics of cancer patients presenting to an integrative medicine practice-based research network. Integr Cancer Ther. 2014 Sep; 13(5):405-10.
    View on PubMed
  10. Non-AIDS-Defining Malignancies in the HIV-Infected Population. Curr Infect Dis Rep. 2014 Jun; 16(6):406.
    View on PubMed
  11. Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative study. J Altern Complement Med. 2014 May; 20(5):364-70.
    View on PubMed
  12. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. BMC Infect Dis. 2013; 13:471.
    View on PubMed
  13. The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms. J Psychoactive Drugs. 2013 Jul-Aug; 45(3):199-210.
    View on PubMed
  14. The BraveNet prospective observational study on integrative medicine treatment approaches for pain. BMC Complement Altern Med. 2013; 13:146.
    View on PubMed
  15. It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park). 2013 May; 27(5):430-7.
    View on PubMed
  16. Integrating dietary supplements into cancer care. Integr Cancer Ther. 2013 Sep; 12(5):369-84.
    View on PubMed
  17. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012 Nov 13; 26(17):2223-31.
    View on PubMed
  18. Patients seek integrative medicine for preventive approach to optimize health. Explore (NY). 2012 Nov-Dec; 8(6):348-52.
    View on PubMed
  19. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat. 2012; 2012:103072.
    View on PubMed
  20. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma. Clin Cancer Res. 2012 Sep 1; 18(17):4702-12.
    View on PubMed

Go to UCSF Profiles, powered by CTSI